Caliper, Shimadzu Settle Patent Litigation

Shimadzu denied infringing the patents, but it agreed to discontinue sales of the MultiNA system in the US.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.